ADHD Diagnosis, Treatment, and Care Clinical Practice Guideline

Australian Medical Association

The National Health and Medical Research Council have approved the Australian ADHD Professionals Association’s Evidence-Based Clinical Practice Guideline for ADHD.

The guidelines allow GPs to be the front-line health professionals in not only identifying patients with ADHD, but also in diagnosis and treatment.

The Guidelines contain 111 clinical recommendations addressing the ADHD journey across a person’s lifespan, from identification and diagnosis to an evolving support plan and information for family, friends, employers, and others in their life. Until now, GPs haven’t been allowed to formally diagnose ADHD, which has made it more difficult and time-consuming for Australians to get a diagnosis in the first place. ADHD is the most common neurodevelopmental disorder, affecting around 800,000 Australians, including approximately 281,000 children, aged 0-19 years.

The guideline covers elements such as identification, diagnosis, treatment and support, non-pharmacological interventions, pharmacological interventions, and other considerations.

You can access the Australian Evidence-Based Clinical Practice Guideline For Attention Deficit Hyperactivity Disorder (ADHD) here.

/AMA/AusMed News. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).